自动化腹膜透析治疗尿毒症伴充血性心衰的临床应用

Clinical application of automated peritoneal dialysis in the treatment of uremia with congestive heart failure

探讨自动化腹膜透析(APD)治疗尿毒症伴充血性心力衰竭(CHF)患者的效果。回顾性分析以腹膜透析为起始肾替代治疗的尿毒症患者共120例,分为APD组、不卧床持续腹膜透析(CAPD)组及血液透析(HD)组,每组各40例,比较3组患者的临床疗效及心功能相关指标的变化。经治疗后,APD组完全缓解率(92.5%)显著高于CAPD组(65.0%)及HD组(75.0%),差异具有统计学意义(P<0.05)。同时,APD组心功能相关指标改善情况显著优于CAPD组及HD组,差异具有统计学意义(P<0.05)。APD对尿毒症伴有CHF患者的治疗效果与传统方法相比,缓解率高,利于改善心功能指标,提高患者的生活质量。

To investigate the efficacy of automated peritoneal dialysis(APD)in the treatment of uremic patients with congestive heart failure(CHF).A total of 120 patients with uremia who underwent renal replacement therapy with peritoneal dialysis were retrospectively analyzed and divided into APD group,continuous ambulatory peritoneal dialysis(CAPD)group and hemodialysis(HD)group,with 40 cases in each group.The clinical curative effect and the changes of related indexes of cardiac function in three groups of patients were compared.After treatment,the complete remission rate(92.5%)in APD group was significantly higher than that in CAPD group(65.0%)and HD group(75.0%),with a significant difference(P<0.05).At the same time,the improvement of heart function related indicators in the APD group was significantly better than that in the CAPD group and the HD group,with a significant difference(P<0.05).The therapeutic effect of APD on uremic patients with CHF is higher than that of the traditional method,which helps to improve the cardiac function index and improve the patient s quality of life.